Analysis and Commentary STEVEN GROSSMAN 5/21/21 Analysis and Commentary STEVEN GROSSMAN 5/21/21 Messaging for Upcoming Senate Hill Days Read More Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Hill Days focusing on Senate staff on May 25 and 26. Alliance webinars upcoming with CDER Director Cavazzoni and FDA’s food and animal health leadership. Read More Analysis and Commentary STEVEN GROSSMAN 1/21/21 Analysis and Commentary STEVEN GROSSMAN 1/21/21 Leadership and FDA Appropriation for FY 22 Read More Analysis and Commentary STEVEN GROSSMAN 1/8/21 Analysis and Commentary STEVEN GROSSMAN 1/8/21 Now We Know Who'll Be in Charge Read More Analysis and Commentary STEVEN GROSSMAN 10/16/20 Analysis and Commentary STEVEN GROSSMAN 10/16/20 Future Changes in Congressional Committees and the FDA Read More Analysis and Commentary STEVEN GROSSMAN 8/14/20 Analysis and Commentary STEVEN GROSSMAN 8/14/20 "Somehow the CR Will Pass", But When? Read More Advocacy at a Glance STEVEN GROSSMAN 8/7/20 Advocacy at a Glance STEVEN GROSSMAN 8/7/20 What We Learned: A Meeting with CDER Deputy Center Director for Operations Dr. Patrizia Cavazzoni Read More Advocacy at a Glance STEVEN GROSSMAN 8/1/20 Advocacy at a Glance STEVEN GROSSMAN 8/1/20 House Will Pause Once It Has Completed 10 of 12 Appropriations Bills Read More Analysis and Commentary STEVEN GROSSMAN 7/18/20 Analysis and Commentary STEVEN GROSSMAN 7/18/20 Why No Movement in the Senate? Read More Advocacy at a Glance STEVEN GROSSMAN 7/18/20 Advocacy at a Glance STEVEN GROSSMAN 7/18/20 House to Consider FY 21 Minibus that Contains Ag/FDA Funding, Scheduled for Next Week Read More Advocacy at a Glance STEVEN GROSSMAN 6/5/20 Advocacy at a Glance STEVEN GROSSMAN 6/5/20 Commissioner Hahn’s Address to the Alliance Gains Wide Attention Read More STEVEN GROSSMAN 11/21/19 STEVEN GROSSMAN 11/21/19 Senate HELP Committee Interviews Stephen Hahn, MD Read More Analysis and Commentary STEVEN GROSSMAN 9/20/19 Analysis and Commentary STEVEN GROSSMAN 9/20/19 More Questions and More Answers ... Once Again Read More Advocacy at a Glance STEVEN GROSSMAN 9/20/19 Advocacy at a Glance STEVEN GROSSMAN 9/20/19 Senate Unveils Proposed $80 Million Increase for FDA Read More Analysis and Commentary STEVEN GROSSMAN 9/13/19 Analysis and Commentary STEVEN GROSSMAN 9/13/19 CR-Level Funding at Start of FY 20 Approaches Certainty Read More Analysis and Commentary STEVEN GROSSMAN 8/23/19 Analysis and Commentary STEVEN GROSSMAN 8/23/19 Sometimes Things Just Don't Go as Planned (or Hoped) Read More Analysis and Commentary STEVEN GROSSMAN 11/2/18 Analysis and Commentary STEVEN GROSSMAN 11/2/18 Changes Are Inevitable. Some Predictable; Others Not Read More STEVEN GROSSMAN 9/7/18 STEVEN GROSSMAN 9/7/18 Timing, Knowns, and Unknowns: FDA's FY 19 Appropriation Read More Analysis and Commentary STEVEN GROSSMAN 8/31/18 Analysis and Commentary STEVEN GROSSMAN 8/31/18 On the Physical Capabilities of a Lame Duck Read More Analysis and Commentary STEVEN GROSSMAN 5/24/18 Analysis and Commentary STEVEN GROSSMAN 5/24/18 FY 19 Funding: House and Senate Proposals Read More Older Posts
Analysis and Commentary STEVEN GROSSMAN 5/21/21 Analysis and Commentary STEVEN GROSSMAN 5/21/21 Messaging for Upcoming Senate Hill Days Read More
Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Hill Days focusing on Senate staff on May 25 and 26. Alliance webinars upcoming with CDER Director Cavazzoni and FDA’s food and animal health leadership. Read More
Analysis and Commentary STEVEN GROSSMAN 1/21/21 Analysis and Commentary STEVEN GROSSMAN 1/21/21 Leadership and FDA Appropriation for FY 22 Read More
Analysis and Commentary STEVEN GROSSMAN 1/8/21 Analysis and Commentary STEVEN GROSSMAN 1/8/21 Now We Know Who'll Be in Charge Read More
Analysis and Commentary STEVEN GROSSMAN 10/16/20 Analysis and Commentary STEVEN GROSSMAN 10/16/20 Future Changes in Congressional Committees and the FDA Read More
Analysis and Commentary STEVEN GROSSMAN 8/14/20 Analysis and Commentary STEVEN GROSSMAN 8/14/20 "Somehow the CR Will Pass", But When? Read More
Advocacy at a Glance STEVEN GROSSMAN 8/7/20 Advocacy at a Glance STEVEN GROSSMAN 8/7/20 What We Learned: A Meeting with CDER Deputy Center Director for Operations Dr. Patrizia Cavazzoni Read More
Advocacy at a Glance STEVEN GROSSMAN 8/1/20 Advocacy at a Glance STEVEN GROSSMAN 8/1/20 House Will Pause Once It Has Completed 10 of 12 Appropriations Bills Read More
Analysis and Commentary STEVEN GROSSMAN 7/18/20 Analysis and Commentary STEVEN GROSSMAN 7/18/20 Why No Movement in the Senate? Read More
Advocacy at a Glance STEVEN GROSSMAN 7/18/20 Advocacy at a Glance STEVEN GROSSMAN 7/18/20 House to Consider FY 21 Minibus that Contains Ag/FDA Funding, Scheduled for Next Week Read More
Advocacy at a Glance STEVEN GROSSMAN 6/5/20 Advocacy at a Glance STEVEN GROSSMAN 6/5/20 Commissioner Hahn’s Address to the Alliance Gains Wide Attention Read More
STEVEN GROSSMAN 11/21/19 STEVEN GROSSMAN 11/21/19 Senate HELP Committee Interviews Stephen Hahn, MD Read More
Analysis and Commentary STEVEN GROSSMAN 9/20/19 Analysis and Commentary STEVEN GROSSMAN 9/20/19 More Questions and More Answers ... Once Again Read More
Advocacy at a Glance STEVEN GROSSMAN 9/20/19 Advocacy at a Glance STEVEN GROSSMAN 9/20/19 Senate Unveils Proposed $80 Million Increase for FDA Read More
Analysis and Commentary STEVEN GROSSMAN 9/13/19 Analysis and Commentary STEVEN GROSSMAN 9/13/19 CR-Level Funding at Start of FY 20 Approaches Certainty Read More
Analysis and Commentary STEVEN GROSSMAN 8/23/19 Analysis and Commentary STEVEN GROSSMAN 8/23/19 Sometimes Things Just Don't Go as Planned (or Hoped) Read More
Analysis and Commentary STEVEN GROSSMAN 11/2/18 Analysis and Commentary STEVEN GROSSMAN 11/2/18 Changes Are Inevitable. Some Predictable; Others Not Read More
STEVEN GROSSMAN 9/7/18 STEVEN GROSSMAN 9/7/18 Timing, Knowns, and Unknowns: FDA's FY 19 Appropriation Read More
Analysis and Commentary STEVEN GROSSMAN 8/31/18 Analysis and Commentary STEVEN GROSSMAN 8/31/18 On the Physical Capabilities of a Lame Duck Read More
Analysis and Commentary STEVEN GROSSMAN 5/24/18 Analysis and Commentary STEVEN GROSSMAN 5/24/18 FY 19 Funding: House and Senate Proposals Read More
